ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.60
      0.87%
      US Tech 100
      16,788.80
      0.21%
      Dow Jones
      38,239.98
      0.67%
      Brent Oil
      86.735
      0.38%
      Bitcoin
      66,285.29
      -0.86%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Algernon Pharmaceuticals Inc (QB) (AGNPF)

      7. Algernon Pharmaceuticals Inc (QB) (AGNPF) News

      AGNPF

      Algernon Pharmaceuticals (QB) (AGNPF)

      Algernon Pharmaceuticals Inc (QB)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:AGNPF
      DateTimeSourceHeadlineSymbolCompany
      12:49PMiHub NewswireFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      06/03/20226:03AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      05/09/20227:41AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      04/25/20226:05AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      04/15/20226:34AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      04/06/20225:28PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      03/24/20226:08AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      02/22/20226:04AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      02/11/20218:00AMInvestorsHub NewsWireAlgernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study ProtocolUSOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      06/04/202012:41PMInvestorsHub NewsWireAlgernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      05/27/20203:14PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      04/13/20209:44AMInvestorsHub NewsWireAlgernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) HowardUSOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
      03/13/20208:40AMInvestorsHub NewsWireAlgernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and EmergencyUSOTC:AGNPFAlgernon Pharmaceuticals Inc (QB)
       Showing the most relevant articles for your search:USOTC:AGNPF